Adoptive immunotherapy of feline leukemia virus infection using autologous lymph node lymphocytes

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 1, 1998, Pages 1-6

  Blakeslee, James ^a   Noll, Greg ^a   Olsen, Richard ^a   Triozzi, Pierre L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Adoptive immunotherapy; Immunodeficiency; Interleukin 2; Retrovirus

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CAT; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE LEUKEMIA VIRUS; FEVER; LYMPH NODE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS INFECTION; TREATMENT PLANNING; VIRUS CULTURE;

ANIMALIA; FELIDAE; FELINE LEUKEMIA VIRUS; FELIS CATUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0032079795     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199805010-00001     Document Type: Article

References (22)

1. Rosenberg SA. Adoptive cellular therapy: clinical applications. In DeVita VT, Hellman S, Rosenberg SA, eds. Biologic therapy of cancer. Philadelphia: JB Lippincott, 1991:214-36.
2. Osband ME, Lavin PT, Babayan RK, et al. Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. Lancet 1990;335:994-8.
3. + cytotoxic T cell therapy of cytomegalovirus and HIV infection. Curr Opin Immunol 1993;5:484-91.
4. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257: 238-40.
5. Heslop HE, Ng CYC, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 1996;2: 551-5.
6. + T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS. Blood 1993;81:2093-101.
7. + T lymphocytes on immunologic parameters: lymphocyte subsets and cytotoxic activity. Clin Immunol Immunopathol 1993;68:263-72
8. Klimas N, Patarca R, Walling J, et al. Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion. AIDS 1994;8:1073-81.
9. Olsen RG, Lewis MG, Lafrado LJ, et al. Feline leukemia virus: current status of the feline induced immune depression and immunoprevention. Cancer Metastasis Rev 1987;6:243-60.
10. Zeidner NS, Mathiason-DuBard CK, Hoover EA. Reversal of feline leukemia virus infection by adoptive transfer of lectin/ interleukin-2-activated lymphocytes, interferon-α, and zidovudine. J Immunother 1993;14:22-32.
11. Mathes LE, Polas PJ, Hayes KA, Swenson CL, Johnson S, Kociba GJ. Pre- and postexposure chemoprophylaxis: evidence that 3′-azido-3′-dideoxythymide inhibits feline leukemia virus disease by a drug-induced vaccine response. Antimicrob Agents Chemother 1992;36:2715-21.
12. Hadida F, Haas G, Zimmermann N, et al. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. J Immunol 1995;154:4174-86.
13. Mullins JI, Hoover EA, Quackenbush SL, Donahue PR. Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1991;4:547-57.
14. Talmadge JE, Phillips H, Schindler J, Tribble H, Pennington R. Systemic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease. Cancer Res 1987;47:5725-32.
15. Thompkins MB, Pang VF, Michaely PA, et al. Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2. J Immmunol 1989;143:749-54.
16. Thompkins MB, Novotney C, Grindem CB, et al. Human recombinant interleukin-2 induces maturation and activation signals for feline eosinophils in vivo. J Leukoc Biol 1990;48:531-40.
17. Walker BD, Flexner C, Birch-Limberger K, et al. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1989;86:9514-8.
18. Tizard IR. Feline immune system. In Roitt IM, Delves PJ, eds. Encyclopedia of immunology. San Diego: Academic Press, 1992:522-5.
19. Hardy WD, Zuckerman EE. Ten-year study comparing enzyme-linked immunosorbent assay with the immunofluorescence antibody test for detection of feline leukemia virus infection in cats. J Am Vet Med Assoc 1991;199:1365-73
20. Moran PA, Diegel ML, Sias JC, Ledbetter JA, Zarling JM. Regulation of HIV production by blood mononuclear cells from HIV-infected donors. I. Lack of correlation between HIV-1 production and T cell activation. AIDS Res Human Retroviruses 1993;9:455-64.
21. + cell antiviral factor. Cell Immunol 1994;153:329-43.
22. Scherle P, Gerhard W. Functional analysis of influenza-specific helper T cell clones in vivo: T cells specific for internal viral protein provide cognate help for B cell responses to hemagglutinin. J Exp Med 1986;164:1114-21.